Advanced Medical Solutions Group plc EBITDA Margin for the year ending December 31, 2024: 16.72%

Advanced Medical Solutions Group plc EBITDA Margin is 16.72% for the year ending December 31, 2024, a -32.79% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Advanced Medical Solutions Group plc EBITDA Margin for the year ending December 31, 2023 was 24.88%, a -11.47% change year over year.
Advanced Medical Solutions Group plc EBITDA Margin for the year ending December 31, 2022 was 28.10%, a 3.64% change year over year.
Advanced Medical Solutions Group plc EBITDA Margin for the year ending December 31, 2021 was 27.12%, a 34.27% change year over year.
Advanced Medical Solutions Group plc EBITDA Margin for the year ending December 31, 2020 was 20.20%, a -31.36% change year over year.

LSE:AMS.L

Advanced Medical Solutions Group plc EBITDA Margin for the year ending December 31, 2024: 16.72%